Literature DB >> 19659474

Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors.

Hiroyuki Kumamoto1, Kousuke Ohki.   

Abstract

BACKGROUND: To investigate the roles of stem cell-related molecules in oncogenesis and cytodifferentiation of odontogenic tumors, expression of CD133, Bmi-1, and ATP-binding cassette subfamily G member 2 (ABCG2) was analyzed in ameloblastic tumors as well as in tooth germs.
METHODS: Tissue specimens of 12 tooth germs, 47 ameloblastomas, and six malignant ameloblastic tumors were examined using reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry to determine the expression of CD133, Bmi-1, and ABCG2.
RESULTS: mRNA expression of CD133, Bmi-1, and ABCG2 was detected in all samples of normal and neoplastic odontogenic tissues. Immunohistochemical reactivity for CD133 and Bmi-1 was evident in odontogenic epithelial cells neighboring the basement membrane in tooth germs, ameloblastomas, and metastasizing ameloblastomas, and ameloblastic carcinomas and clear cell odontogenic carcinomas showed reactivity for CD133 and Bmi-1 in most neoplastic cells. The level of CD133 immunoreactivity in malignant ameloblastic tumors was significantly higher than the levels in tooth germs and ameloblastomas. Immunoreactivity for ABCG2 in odontogenic epithelial components was detected in some ameloblastic tumors but not in tooth germ tissues. Some granular neoplastic cells in granular cell ameloblastomas showed ABCG2 expression. The level of ABCG2 immunoreactivity in malignant ameloblastic tumors was significantly higher than that in tooth germs.
CONCLUSION: Expression of CD133, Bmi-1, and ABCG2 in tooth germs and ameloblastic tumors suggests that stem cell-related molecules might control the maintenance of odontogenic tissues. Expression of these molecules is possibly involved in oncogenesis, cell differentiation, and malignant potential of odontogenic epithelium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19659474     DOI: 10.1111/j.1600-0714.2009.00807.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  11 in total

1.  Emerging strategies for the identification and targeting of cancer stem cells.

Authors:  Jun Dou; Ning Gu
Journal:  Tumour Biol       Date:  2010-03-25

2.  GWAS of dental caries patterns in the permanent dentition.

Authors:  J R Shaffer; E Feingold; X Wang; M Lee; K Tcuenco; D E Weeks; R J Weyant; R Crout; D W McNeil; M L Marazita
Journal:  J Dent Res       Date:  2012-10-11       Impact factor: 6.116

Review 3.  Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Authors:  Karthika Natarajan; Yi Xie; Maria R Baer; Douglas D Ross
Journal:  Biochem Pharmacol       Date:  2012-01-11       Impact factor: 5.858

4.  Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.

Authors:  Te Liu; Fuhui Xu; Xiling Du; Dongmei Lai; Tianjin Liu; Yarui Zhao; Qin Huang; Lizhen Jiang; Wenbin Huang; Weiwei Cheng; Zhixue Liu
Journal:  Mol Cell Biochem       Date:  2010-03-12       Impact factor: 3.396

5.  Analysis of immunoexpression of common cancer stem cell markers in ameloblastoma.

Authors:  Gulsan Ara Sathi; Ryo Tamamura; Hidetsugu Tsujigiwa; Naoki Katase; Mathieu Lefeuvre; Chong Huat Siar; Hiroyuki Matsuda; Hitoshi Nagatsuka
Journal:  Exp Ther Med       Date:  2011-12-28       Impact factor: 2.447

6.  miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.

Authors:  Shujing Liu; Michael T Tetzlaff; Rutao Cui; Xiaowei Xu
Journal:  Am J Pathol       Date:  2012-09-13       Impact factor: 4.307

Review 7.  Ameloblastic carcinoma of the mandible: Report of a case and review.

Authors:  Shreenivas Kallianpur; Sanjay Jadwani; Biswajit Misra; U S Sudheendra
Journal:  J Oral Maxillofac Pathol       Date:  2014-09

Review 8.  BMI1: A Biomarker of Hematologic Malignancies.

Authors:  Anagh A Sahasrabuddhe
Journal:  Biomark Cancer       Date:  2016-05-05

Review 9.  Molecular and genetic aspects in the etiopathogenesis of ameloblastoma: An update.

Authors:  Ravleen Nagi; Shashikant Sahu; N Rakesh
Journal:  J Oral Maxillofac Pathol       Date:  2016 Sep-Dec

10.  Activation of Wnt signalling reduces the population of cancer stem cells in ameloblastoma.

Authors:  Hyun-Yi Kim; Shujin Li; Dong-Joon Lee; Jin Hoo Park; Takashi Muramatsu; Hidemitsu Harada; Young-Soo Jung; Han-Sung Jung
Journal:  Cell Prolif       Date:  2021-06-06       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.